ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,267.84
      -0.74%
      US Tech 100
      18,197.60
      0.28%
      Dow Jones
      39,065.26
      0.00%
      Brent Oil
      80.90
      -0.50%
      Bitcoin
      67,300.65
      -0.92%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Gemphire Therapeutics Inc (GEMP)

      7. Gemphire Therapeutics Inc (GEMP) News

      GEMP

      Gemphire Therapeutics (GEMP)

      Gemphire Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GEMP
      DateTimeSourceHeadlineSymbolCompany
      12/31/20196:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
      12/30/201911:24AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
      12/30/201911:22AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
      12/30/201911:08AMGlobeNewswire Inc.Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo PharmaceuticalsNASDAQ:GEMPGemphire Therapeutics Inc
      12/06/20194:25PMEdgar (US Regulatory)Unknown (sec Staff)NASDAQ:GEMPGemphire Therapeutics Inc
      12/06/20194:24PMEdgar (US Regulatory)Unknown (sec Staff)NASDAQ:GEMPGemphire Therapeutics Inc
      12/06/20194:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
      12/06/20194:03PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
      12/06/20198:43AMGlobeNewswire Inc.Gemphire Therapeutics Announces Stockholder Approval of Proposals Required for Merger with NeuroBo PharmaceuticalsNASDAQ:GEMPGemphire Therapeutics Inc
      11/08/20199:25AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GEMPGemphire Therapeutics Inc
      11/07/20196:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GEMPGemphire Therapeutics Inc
      11/06/20199:16AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GEMPGemphire Therapeutics Inc
      11/04/20194:27PMEdgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:GEMPGemphire Therapeutics Inc
      10/30/20196:21AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
      10/30/20196:10AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
      10/11/20196:02AMEdgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:GEMPGemphire Therapeutics Inc
      10/08/20194:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
      10/08/20194:03PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
      10/03/20194:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
      10/03/20194:04PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
      09/24/20194:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
      09/24/20194:17PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
      09/03/20196:03AMEdgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:GEMPGemphire Therapeutics Inc
      08/15/20198:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
      08/15/20198:01AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
      08/13/20195:27PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:GEMPGemphire Therapeutics Inc
      08/13/20195:26PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
      08/09/20198:29AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GEMPGemphire Therapeutics Inc
      08/05/20198:22AMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:GEMPGemphire Therapeutics Inc
      08/02/20195:24PMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:GEMPGemphire Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:GEMP